Client News

PL BioScience Wins Regulatory Certification from Japan’s PMDA

Rentschler Biopharma appoints Dr. Veit Bergendahl as Chief Operating Officer and member of the executive board

Lotus Pharmaceutical becomes commercialization partner for Formycon’s Keytruda® biosimilar candidate FYB206 across major parts of the Asia-Pacific Region

CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface (BCI) System

Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia

InflaRx Announces Participation in February Investor Conferences

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.

Mallia selected as Innovation Tank finalist at IMCAS World Congress 2026

Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy

ARTCLINE appoints Peter Llewellyn-Davies as Chairman of the Supervisory Board and accelerates commercialization of innovative sepsis therapy